Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Marksans Pharma Limited
Press Release May 15 2025
Business
May 15 2025
3 min read

Press Release May 15 2025

Marksans Pharma Limited has informed the Exchange regarding a press release dated May 15, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for the product Gabapentin 50 mg/ml oral solution".

View Attachment